Cilastatin sodium是一种可逆的竞争性肾脏脱氢肽酶 I (renal dehydropeptidase I) 抑制剂,IC50 为 0.1 μM,同时抑制细菌金属酶 CphA,IC50 为 178 μM,可作为抗生素的辅助剂使用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| Concentration | Treated Time | Description | References | |
| Porcine renal proximal tubular epithelial cells (RPTECs) | 200 µg/mL | 24 h | Cilastatin significantly reduced gentamicin-induced apoptosis, as evidenced by preserved cell morphology and reduced cell detachment. Additionally, Cilastatin decreased caspase-3 activation and nucleosomal DNA fragmentation. | Antioxidants (Basel). 2020 Sep 3;9(9):821 |
| rabbit primary proximal tubule cells (rPTCs) | 100 µM | 10 min | To evaluate the inhibitory effect of Cilastatin on Imipenem uptake in rPTCs, results showed that Cilastatin significantly inhibited Imipenem uptake. | Acta Pharm Sin B. 2019 Sep;9(5):986-996 |
| hOAT3-HEK293 cells | 100 µM | 10 min | To evaluate the inhibitory effect of Cilastatin on Imipenem uptake in hOAT3-HEK293 cells, results showed that Cilastatin significantly inhibited Imipenem uptake. | Acta Pharm Sin B. 2019 Sep;9(5):986-996 |
| hOAT1-HEK293 cells | 100 µM | 10 min | To evaluate the inhibitory effect of Cilastatin on Imipenem uptake in hOAT1-HEK293 cells, results showed that Cilastatin significantly inhibited Imipenem uptake. | Acta Pharm Sin B. 2019 Sep;9(5):986-996 |
| Administration | Dosage | Frequency | Description | References | ||
| Kunming mice | Diclofenac-induced acute kidney injury model | Intraperitoneal injection | 25-100 mg/kg | Single dose, duration of 24 hours | To evaluate the protective effect of Cilastatin on diclofenac-induced acute kidney injury. Results showed that Cilastatin reduced renal pathological changes, dysfunction, oxidative stress, and inflammation, and decreased the renal distribution of diclofenac and its metabolite DLF-AG. | Br J Pharmacol. 2020 May;177(9):1933-1948. |
| Wistar rats | Gentamicin-induced acute kidney injury model | Intraperitoneal injection | 150 mg/kg | Once daily for 8 days | Cilastatin significantly ameliorated gentamicin-induced renal dysfunction, including reductions in serum creatinine, blood urea nitrogen (BUN), and kidney injury molecule-1 (KIM-1) levels. Furthermore, Cilastatin reduced morphological kidney damage, apoptosis, oxidative stress, and inflammatory responses. | Antioxidants (Basel). 2020 Sep 3;9(9):821 |
| Wistar rats | Cisplatin-induced nephrotoxicity model | Intraperitoneal injection | 150 mg/kg | Once daily for 5 days | Cilastatin significantly attenuated cisplatin-induced nephrotoxicity, including body weight loss, renal dysfunction (assessed by GFR, serum creatinine, and BUN), morphological renal lesions, apoptotic cell death, and lipid peroxidation. Additionally, Cilastatin restored cisplatin-induced alterations in renal lipid distribution. | J Lipid Res. 2018 Sep;59(9):1561-1574 |
| New Zealand white rabbits | Imipenem-induced acute kidney injury model | Intravenous injection | 200 mg/kg | Single dose, observed for 48 hours | To evaluate the protective effect of Cilastatin on Imipenem-induced nephrotoxicity, results showed that Cilastatin significantly alleviated kidney injury. | Acta Pharm Sin B. 2019 Sep;9(5):986-996 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.63mL 0.53mL 0.26mL |
13.14mL 2.63mL 1.31mL |
26.29mL 5.26mL 2.63mL |
|
| CAS号 | 81129-83-1 |
| 分子式 | C16H25N2NaO5S |
| 分子量 | 380.43 |
| SMILES Code | O=C([O-])/C(NC([C@@H]1C(C)(C)C1)=O)=C/CCCCSC[C@H](N)C(O)=O.[Na+] |
| MDL No. | MFCD08459332 |
| 别名 | MK0791 sodium |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
H2O: 100 mg/mL(262.86 mM),配合低频超声助溶 |
沪公网安备 31011702889066号
沪ICP备2024050318号-1